Skip to main content
. Author manuscript; available in PMC: 2010 Aug 11.
Published in final edited form as: IEEE Trans Neural Syst Rehabil Eng. 2008 Apr;16(2):195–204. doi: 10.1109/TNSRE.2008.918425

TABLE IV.

Simulated Selectivity Values

Target Fascicular Group FINE Opening Height
3.8 mm 2.3 mm 1.4 mm
22-contact FINE
 Sartorius 0.52±0.06 0.38±0.04 0.51±0.05
 Rectus Femoris 0.42±0.05 0.51±0.06 0.44±0.05
 Vastus Lateralis 0.11±0.05 0.17±0.05 0.24±0.12
 Vastus Intermedius 0.47±0.08 0.62±0.10 0.51±0.15
 Vastus Medialis 0.28±0.04 0.44±0.04 0.45±0.05
 Pectineus 0.61±0.07 0.74±0.08 0.46±0.18

FINE11A/B
 Sartorius 0.36±0.21 0.35±0.26 0.42±0.30
 Rectus Femoris 0.29±0.24 0.36±.027 0.39±0.33
 Vastus Lateralis 0.07±0.08 0.09±0.12 0.16±.012
 Vastus Intermedius 0.24±0.25 0.31±0.32 0.25±0.28
 Vastus Medialis 0.19±0.14 0.25±.021 0.30±0.17
 Pectineus 0.31±0.33 0.37±0.40 0.23±0.27

FINE 8A/B
 Sartorius 0.46±0.11 0.36±0.23 0.40±0.27
 Rectus Femoris 0.32±0.24 0.33±0.30 0.40±0.33
 Vastus Lateralis 0.07±0.08 0.10±0.11 0.16±0.12
 Vastus Intermedius 0.27±0.17 0.31±0.28 0.25±0.28
 Vastus Medialis 0.16±0.14 0.16±0.18 0.12±0.13
 Pectineus 0.58±0.13 0.59±0.22 0.24±0.26

FINE 8C
 Sartorius 0.40±0.12 0.37±0.23 0.33±0.33
 Rectus Femoris 0.28±0.24 0.27±0.30 0.35±0.37
 Vastus Lateralis 0.02±0.03 0.03±0.05 0.00±0.00
 Vastus Intermedius 0.40±0.12 0.38±0.29 0.51±0.15
 Vastus Medialis 0.20±0.17 0.12±0.17 0.14±0.15
 Pectineus 0.56±0.10 0.47±0.18 0.46±0.18

FINE 6A/B
 Sartorius 0.33±0.15 0.35±0.25 0.35±0.35
 Rectus Femoris 0.26±0.21 0.30±0.28 0.36±0.33
 Vastus Lateralis 0.00±0.00 0.02±0.04 0.00±0.00
 Vastus Intermedius 0.22±0.21 0.19±0.28 0.25±0.28
 Vastus Medialis 0.14±0.14 0.10±0.13 0.12±0.13
 Pectineus 0.44±0.26 0.28±0.24 0.23±0.27

FINE 6C
 Sartorius 0.40±0.12 0.37±0.23 0.33±0.33
 Rectus Femoris 0.28±0.24 0.27±0.30 0.35±0.37
 Vastus Lateralis 0.00±0.00 0.00±0.00 0.00±0.00
 Vastus Intermedius 0.22±0.24 0.30±.032 0.00±0.00
 Vastus Medialis 0.21±0.17 0.30±0.22 0.45±0.08
 Pectineus 0.00±0.00 0.00±0.00 0.00±0.00

Selectivity and standard deviations obtained during stimulation via a single contact (“choose-1”) in which non-target muscles could not be activated above threshold (0.10). Values were obtained by averaging the five randomized populations for each cross-section across the three unique cross-sections. A/B data are averaged from the individual A and B configurations. Black cells indicate fascicle groups for which costs exceeded threshold before benefits exceeded threshold.